NewAmsterdam Pharma Co N.V. - NAMS

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A VIKING GLOBAL INVESTORS LP 3.7% 4,203,567 View
Feb 17, 2026 SCHEDULE 13G/A Viking Global Opportunities Parent GP LLC 3.7% 4,203,567 View
Feb 17, 2026 SCHEDULE 13G/A Viking Global Opportunities GP LLC 2.5% 2,817,205 View
Feb 17, 2026 SCHEDULE 13G/A Viking Global Opportunities Portfolio GP LLC 2.5% 2,817,205 View
Feb 17, 2026 SCHEDULE 13G/A Viking Global Opportunities Illiquid Investments Sub-Master LP 2.5% 2,817,205 View
Feb 17, 2026 SCHEDULE 13G/A Viking Global Opportunities Drawdown GP LLC 1.2% 1,386,362 View
Feb 17, 2026 SCHEDULE 13G/A Viking Global Opportunities Drawdown Portfolio GP LLC 1.2% 1,386,362 View
Feb 17, 2026 SCHEDULE 13G/A Viking Global Opportunities Drawdown (Aggregator) LP 1.2% 1,386,362 View
Feb 17, 2026 SCHEDULE 13G/A HALVORSEN OLE ANDREAS 3.7% 4,203,567 View
Feb 17, 2026 SCHEDULE 13G/A Ott David C. 3.7% 4,203,567 View
Feb 17, 2026 SCHEDULE 13G/A Shabet Rose Sharon 3.7% 4,203,567 View
Feb 05, 2026 SCHEDULE 13G FMR LLC 5.7% 6,412,984 View
Feb 05, 2026 SCHEDULE 13G Abigail P. Johnson 5.7% 6,412,984 View
Dec 04, 2025 SCHEDULE 13D/A 4.7% View
Nov 13, 2025 SCHEDULE 13G/A Capital World Investors 8.7% 9,822,711 View
Nov 07, 2025 SCHEDULE 13D/A 9.99% View
Nov 04, 2025 SCHEDULE 13D/A View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.